Pharma Exclusives Pressreleases
BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative
Tuesday, September 02, 2025In recognition of Peripheral Artery Disease PAD Awareness Month BD Becton Dickinson and Company NYSE BDX is shining a spotlight on a serious yet often overlooked circulatory disorder that restricts
Merck’s Investigational Oral PCSK9 Inhibitor Enlicitide Decanoate Met All Primary and Key Secondary Endpoints in Adults with Hypercholesterolemia in Pivotal CORALreef Lipids Study
Tuesday, September 02, 2025Merckknown as MSD outside of the United States and Canada today announced positive topline results from the Phase CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate an investigational
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss
Friday, August 29, 2025Teva Pharmaceuticals Inc a US affiliate of Teva Pharmaceutical Industries Ltd NYSE and TASE TEVA announced today the FDA approval and US launch of a generic version of Saxenda liraglutide injection
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
Thursday, August 28, 2025Moderna Inctoday announced that the US Food and Drug Administration FDA has approved the supplemental Biologics License Applications sBLA for the formulas for Spikevax and mNEXSPIKE
AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline
Monday, August 25, 2025AbbVieand Gilgamesh Pharmaceuticals Inc Gilgamesh today announced a definitive agreement under which AbbVie will acquire Gilgameshs lead investigational candidate currently in clinical development
Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform
Friday, August 22, 2025Kite a Gilead Company today announced that it has entered into a definitive agreement to acquire Interius BioTherapeutics a privately held biotechnology company developing in vivo CAR therapeutics for million
Thermo Fisher Scientific Opens Manufacturing Center of Excellence Site in North Carolina
Friday, August 22, 2025Thermo Fisher Scientific Inc the world leader in serving science today announced the grand opening of its innovative manufacturing center of excellence facility in Mebane NC The new squarefoot carbon neutral site
AbbVie Completes Acquisition of Capstan Therapeutics
Tuesday, August 19, 2025AbbVieannounced today that it has completed its acquisition of Capstan Therapeutics With the completion of the acquisition Capstan is now a part of AbbVie
Ifinatamab Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Pretreated Extensive-Stage Small Cell Lung Cancer
Monday, August 18, 2025Ifinatamab deruxtecan IDXd has been granted Breakthrough Therapy Designation BTD by the US Food and Drug Administration FDA for the treatment of adult patients with extensivestage small
Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia
Saturday, August 16, 2025Tonix Pharmaceuticals Holding Corp a fullyintegrated biotechnology company today announced that the US Food and Drug Administration FDA approved Tonmya cyclobenzaprine HCl sublingual tablets
